The approval was based on additional efficacy data from the ACCESS IUS trial. The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Liletta ® ...

Allergan and Medicines360 announced that the Food and Drug Administration (FDA) has accepted for filing the supplemental New Drug Application (sNDA) for Liletta (levonorgestrel-releasing intrauterine ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Liletta 52 mg intrauterine device continues to safely ...

Zoe Reiches got her first IUD this August — a new model with the lilting name Liletta. Reiches, 25 and a human resources specialist in Boston, is now happily set for birth control for at least three ...

Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, today announced the approval of LILETTA™ ...

Actavis plc, a leading global pharmaceutical company and leader in women's health care, and Medicines360, a nonprofit women's health pharmaceutical company, announced that Liletta ...

In a taupe-walled exam room at the Women’s Community Clinic in San Francisco, lead clinician Lisa Mihaly plucks a small laminated card from a cabinet. Tethered to the card are three T-shaped IUDs, or ...

Please provide your email address to receive an email when new articles are posted on . Actavis and Medicines360 announced today that the FDA has granted approval to intrauterine device, Liletta, for ...

Allergan plc, a leading global pharmaceutical company, launched the Liletta + Liletta Patient Commitment Programme, an innovative programme for eligible patients to obtain a second Liletta at no ...

Allergan plc AGN and partner Medicines360, a nonprofit global women's health pharmaceutical company, announced that the FDA has accepted a supplemental New Drug Application (sNDA) for its marketed ...

Another day, another way to avoid getting pregnant. This time it’s a new IUD called Liletta, which just received FDA approval for use in the United States. (Of course, it’s already been approved for ...

Clinician holding an IUD device The expanded approval was supposed by safety and efficacy data from the Phase 3 ACCESS IUS trial (N=1751) in women receiving Liletta. In the trial, Liletta demonstrated ...